Home > Insider Trading > Filing (0000899243-20-003296)

Filing Details

Accession Number:: 0000899243-20-003296
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-02-05 17:00:23
Reporting Period:: 2020-02-03

Accepted Time:: 2020-02-05 17:00:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1351288	Gw Pharmaceuticals Plc	GWPH	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1754129	D. Justin Gover	Sovereign House, Vision Park, Histon Cambridge X0 CB24 9BZ	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Ordinary Shares	Acquisiton	2020-02-03	202,224	$0.00	765,749	No	4	M	Direct
Ordinary Shares	Disposition	2020-02-03	71,712	$9.57	694,037	No	4	S	Direct
Ordinary Shares	Disposition	2020-02-03	110,964	$9.63	583,073	No	4	S	Direct
Ordinary Shares	Disposition	2020-02-03	19,548	$9.71	563,525	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Ordinary Shares	Stock Options	Disposition	2020-02-03	202,224	$0.00	202,224	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7	2019-02-15	2020-03-15	No	4	M	Direct

Footnotes

Exercise of stock options. Following the exercise, these shares were converted into American Depositary Shares ("ADS") of the Issuer. Each ADS represents twelve ordinary shares of the Issuer.
Converted from British Pounds Sterling to U.S. Dollars using currency ratio of 1.00 British Pound Sterling = 1.30 U.S. Dollars as of February 3, 2020.
The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 3, 2019.
Represented by ADSs.
The price reported in Column 4 is a weighted average price per ordinary share ($114.85 per ADS). These share were sold in multiple transactions at prices ranging from $9.51 per ordinary share ($114.16 per ADS) to $9.60 per ordinary share ($115.15 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($115.52 per ADS). These share were sold in multiple transactions at prices ranging from $9.60 per ordinary share ($115.16 per ADS) to $9.68 per ordinary share ($116.14 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
The price reported in Column 4 is a weighted average price per ordinary share ($116.54 per ADS). These share were sold in multiple transactions at prices ranging from $9.68 per ordinary share ($116.19 per ADS) to $9.76 per ordinary share ($117.07 per ADS), inclusive. The Reporting Person understands to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.